Ticker name:SMMTSummit Therapeutics Inc.

Country: US-Sector: Healthcare, Industry: Biotechnology

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Market Cap 13B

Last close 16.17$

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA139B549.04$
2MRNAModerna, Inc.103B258.38$
3REGNREGENERON PHARMACEUTICALS, INC.96B930.67$
4RVMDRevolution Medicines, Inc.43B199.7$
5GMABGENMAB A/S34B55.12$
6ROIVRoivant Sciences Ltd.28B38.23$
7UTHRUNITED THERAPEUTICS Corp26B608.49$
8INCYINCYTE CORP25B122.85$
9INSMINSMED Inc24B110$
10ALNYALNYLAM PHARMACEUTICALS, INC.22B161.08$
11EXELEXELIXIS, INC.18B72.75$
12ASNDAscendis Pharma A/S17B257.93$
13NBIXNEUROCRINE BIOSCIENCES INC17B166.05$
14BBIOBridgeBio Pharma, Inc.15B77.89$
15JAZZJazz Pharmaceuticals plc15B234.66$
16HALOHALOZYME THERAPEUTICS, INC.15B130.34$
17SMMTSummit Therapeutics Inc.13B16.17$
18KYMRKymera Therapeutics, Inc.12B136.25$
19TECHBIO-TECHNE Corp11B72.73$
20BMRNBIOMARIN PHARMACEUTICAL INC11B57.13$